Characteristics of young illicit drug injectors who use North America's first medically supervised safer injecting facility

References

• Bourgois P, Lettier M, Quesada J. Social misery and the sanctions of substance abuse: Confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems 1997; 44: 155–173
   Google Scholar
• Bundesministerium fur Gesundheit und Soziale Sicherung. Evaluation der Arbeit von Drogenkonsumauen in der Bundesrepulik Deutschland. Nomos, Baden-Baden 2003
   Google Scholar
• Burns JM, Martyres RF, Clode D, Boldero JM. Overdose in young people using heroin: Associations with mental health, prescription drug use and personal circumstances. Medical Journal of Australia 2004; 181: S25–S28
   Google Scholar
• CDCP. HIV/AIDS among youth. Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Washington, DC 2003
   Google Scholar
• Craib KJ, Spittal PM, Wood E, LaLiberte N, Hogg RS, Li K, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Canadian Medical Association Journal 2003; 168: 19–24
   Google Scholar
• Culhane DP, Gollub E, Kuhn R, Shpaner M. The co-occurrence of AIDS and homelessness: Results from the integration of administrative databases for AIDS surveillance and public shelter utilisation in Philadelphia. Journal of Epidemiology and Community Health 2001; 55: 515–520
   Google Scholar
• Dematteo D, Major C, Block B, Coates R, Fearon M, Goldberg E, et al. Toronto street youth and HIV/Aids: Prevalence, demographics, and risks. Journal of Adolescent Health 1999; 25: 358–366
   Google Scholar
• de Jong W, Wever U. The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany, and Switzerland. International Journal of Drug Policy 1999; 10: 99–108
   Google Scholar
• Diaz T, Des Jarlais DC, Vlahov D, Perlis TE, Edwards V, Friedman SR, et al. Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health 2001; 91: 23–30
   Google Scholar
• Fuller CM, Absalon J, Ompad DC, Nash D, Koblin B, Blaney S, et al. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000–2003. Journal of Urban Health 2005; 82: i51–i61
   Google Scholar
• Hahn JA, Page-Shafer K, Lum PJ, Ochao K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34: 180–187
   Google Scholar
• Health Canada. HIV Epi Updates. Surveillance and Risk Assessment Division, Centre for Infectious Disease Control, Public Health Agency of Canada, Ottawa, Ontario 2005
   Google Scholar
• Kemmesies UE. Final report: The open drug scene and the safe injection room offers in Frankfurt am Main. 1999
   Google Scholar
• Kilbourne AM, Herndon B, Anderson RM, Wenzel SL, Gelberg L. Psychiatric symptoms, health services, and HIV risk factors among homeless women. Journal of Health Care for the Poor Underserved 2002; 13: 49–65
   Google Scholar
• Miller CL, Johnston C, Spittal PM, Li K, LaLiberte N, Montaner JS, et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002a; 36: 737–742
   Google Scholar
• Miller CL, Spittal P, Frankish JC, Li K, Schecter MT, Wood E. Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies. 13th Annual Canadian Conference on HIV/AIDS Research. MontrealCanada 2004a
   Google Scholar
• Miller CL, Spittal P, LaLiberte N, Li K, Tyndall MW, O'Shaughnessy MV, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndrome 2002b; 30: 335–341
   Google Scholar
• Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schecter MT. HIV incidence and associated risk factors among young injection drug users. AIDS 2002c; 16: 491–493
   Google Scholar
• Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, et al. The future face of coinfection: Prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. Journal of Acquired Immune Deficiency Syndromes 2004b; 36: 743–749
   Google Scholar
• Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug and Alcohol Dependence 2005; 80: 297–302
   Google Scholar
• Palepu A, Tyndall MW, Leon H, Muller J, O'Shaugnessy MV, Schecter MT, et al. Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal 2001; 165: 415–420
   Google Scholar
• Regidor E, de la Fuente L, Calle ME, Navarro P, Dominguez V. Unusually strong association between education and mortality in young adults in a community with a high rate of injection-drug users. European Journal of Public Health 2003; 13: 334–339
   Google Scholar
• Roy E, Haley N, Leclerc P, Sochanski B, Boudreau JF, Boivin JF. Mortality in a cohort of street youth in Montreal. Journal of the American Medical Association 2004; 292: 569–574
   Google Scholar
• Spittal PM, Craib KJ, Wood E, LaLiberte N, Li K, Tyndall MW, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal 2002; 166: 894–899
   Google Scholar
• Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997; 11: F59–F65
   Google Scholar
• Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003; 17: 887–893
   Google Scholar
• Wall R, Rehm J, Fischer B, Brands B, Gliksman L, Steward J, Medved W, et al. Social costs of untreated opioid dependence. Journal of Urban Health 2000; 77: 688–722
   Google Scholar
• Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW. Methodology for evaluating Insite: Canada. Harm Reduction Journal 2004a; 1: 9
   Google Scholar
• Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, et al. Rationale for evaluating North America. Lancet Infectious Disease 2004b; 4: 301–306
   Google Scholar
• Wood E, Kerr T, Spittal P, Li K, Small W, Tyndall MW, et al. The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes 2003; 32: 2–8
   Google Scholar
• Wood E, Schechter MT, Tyndall MW, Montaner JS, O'Shaughnessy MV, Hogg RS. Antiretroviral medication use among injection drug users: Two potential futures. AIDS 2000; 14: 1229–1235
   Google Scholar
• Wood E, Tyndall M, Spittal P, Li K, Hogg R, O'Shaugnessy MV, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy 2002; 13: 95–102
   Google Scholar
• Wood E, Tyndall M, Li K, Small W, Montaner JS, Kerr T. Do supervised injecting facilities attract higher-risk injection drug users?. American Journal of Preventive Medicine 2005; 29: 126–130
   Google Scholar
• Wood E, Tyndall MW, Spittal P, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Canadian Medical Association Journal 2001; 165: 405–410
   Google Scholar